embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

EMBCV 11.12.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-26
Name of Upcoming Event:embecta fiscal fourth quarter and full year 2024 financial results
Full Press ReleaseSEC FilingsOur EMBCV Tweets

About Gravity Analytica

Recent News

  • 12.19.2024 - embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
  • 11.26.2024 - Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
  • 11.26.2024 - embecta Announces Quarterly Cash Dividend

Recent Filings

    PDF Version135 KB

    PARSIPPANY, N.J.,Nov. 12, 2024(GLOBE NEWSWIRE) --Embecta Corp.(“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at8:00 a.m. Eastern Time(ET) onTuesday, November 26, 2024.

    Those who would like to participate may access the live webcasthere, or access the teleconferencehere. The live webcast can also be accessed via the company’s website atinvestors.embecta.com.

    A webcast replay of the call will be available beginning at11:00 a.m. ETonNov 26, 2024, via the embecta investor relations website and archived on the website for one year.

    About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visitembecta.comor follow our social channels onLinkedIn,Facebook, andInstagram.

    Contacts:

    MediaInvestors
    Christian Glazar

    Pravesh Khandelwal
    Sr. Director, Corporate CommunicationsVP, Head of Investor Relations
    908-821-6922551-264-6547
    Contact Media RelationsContact IR

    Primary Logo

    Source: Embecta Corp.

    Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com